logo

Discover

Categories
Popular Tags
SV logo
Published on: January 12, 2022 at
Biogen's Alzheimer’s Drug Coverage Limited by U.S.
0
0
0
Biogen's Alzheimer’s Drug Coverage Limited by U.S.
The U.S. government limited coverage of Biogen's Alzheimer’s disease treatment and similar drugs through Medicare to patients who are enrolled in clinical trials, a move that will curb access to a controversial treatment that regulators approved last year. Bloomberg's Robert Langreth has more on "Bloomberg Markets: The Close."
Comments 0